All posts tagged: History of Cannabis

Discrepancies in Medical Cannabis Use

Medical Cannabis Use 

A recent letter to the editor exposes the large discrepancy between the number of registered medical marijuana patients and those who self-reported medical cannabis use. Estimates given by the National Survey on Drug Use and Health (NSDUH) suggest that 2.5% of Americans over the age of 12 used medical cannabis in 2013-2015 but a study from 2016 found that only 641,176 people were licensed to receive medical cannabis, a prevalence of 0.4%. If the numbers published by the NSDUH are accurate then states may need to delve into how so many people are accessing medical cannabis without proper licensing in order to better regulate the supply. If the numbers are extrapolated to 2019 and include all states where medical cannabis use in legal then more than 6.2 million people should be licensed but may not be.  

Medical cannabis can be difficult to acquire due to its cost, post-legalization. Although medical cannabis in Massachusetts is readily available with a large number of dispensaries across the state, the cost of obtaining a doctor’s recommendation, complying with state fees, and then paying for the cannabis at a dispensary can be too much for some patients. Although MA will soon be waving the state fee, to obtaining a license, clinicians are still expensive and without the support of the federal government allowing national insurance companies to cover medical cannabis the costs still add up quickly. Fortunately, some dispensaries are designed to cater to those who need financial support.

View this review (yellow link) or download:

To read the Author’s reply:

This paper is also stored here:    http://bit.ly/2K7VQoh and http://bit.ly/2K3rnra     inside the CED Foundation Archive

To explore related information, click the keywords below:

Benjamin Caplan, MDDiscrepancies in Medical Cannabis Use
read more

USA Today Report: Cannabis Consumers Reduce Use of painkillers, prescription drugs, alcohol

“Among all surveyed consumers, 49% reported reducing their over-the-counter painkiller use since starting cannabis, and 52% reduced prescription drug use. Another 37% said they’ve reduced alcohol consumption since starting cannabis”


https://www.leafly.com/news/industry/usa-today-report-cannabis-consumers-reduce-use-of-pills-booze

Benjamin Caplan, MDUSA Today Report: Cannabis Consumers Reduce Use of painkillers, prescription drugs, alcohol
read more

Video: Legalization of Cannabis?

Medical marijuana is legal in 33 states, and recreational marijuana is legal in 11. But on a federal level, the use and possession of marijuana is illegal for any purpose. The illegal status of cannabis prohibits research opportunities and hinders the safety of cannabis sales.

Watch this video for 4 reasons to legalize marijuana on a federal level

Benjamin Caplan, MDVideo: Legalization of Cannabis?
read more

Evaluating the visual cues of quality for cannabis flower

Ever wonder if your cannabis is high or low quality? These visual clues could help you find out

Benjamin Caplan, MDEvaluating the visual cues of quality for cannabis flower
read more

Solo Sciences Press

A sneak peek at the latest news coming about solo sciences, inc!

Imagine a future of cannabis, where consumers have the control of purchase decisions, based on accurate information about the brand and products they may want, and tamper-proof, third-party verification that what we are buying is actually what the package says it is? (and then… consider that this concept applies to products beyond cannabis, from food to beauty products, toys, entertainment…)

“The world of cannabis is murky, unpredictable, and often not safe,” said Ashesh Shah, CEO and founder of solo sciences and a former CIA profiler. “As brands and governments are struggling to fight the illicit market, we created solo* to solve that problem by creating transparency into what cannabis providers are actually selling to consumers. solo* is designed to keep people out of the dark when it comes to what they’re consuming and putting into their bodies, so they feel secure and knowledgeable about the products they’re purchasing.”

https://zd.net/2JQc7hi

for more information about solo*:

Website: https://www.solosciences.com/

LinkedIn: https://www.linkedin.com/company/solo-sciences/

Facebook: https://www.facebook.com/solosciences

Twitter: https://twitter.com/solosciences

Benjamin Caplan, MDSolo Sciences Press
read more

Medical cannabis doctors left to handle “backlash” from patients over lack of availability

Though UK doctors have been able to prescribe cannabis since November 2018, very few prescriptions have been issued, because most forms of medical cannabis have not been approved by the government.

In response to thousands of disappointed patients, the House of Commons Health and Social Care Committee called for immediate clinical trials focusing on the treatment of intractable childhood epilepsy. 

View this review (yellow link) or download:

This paper is also stored here:   http://bit.ly/2XXYrEJ      inside the CED Foundation Archive

To explore related information, click the keywords below:

Benjamin Caplan, MDMedical cannabis doctors left to handle “backlash” from patients over lack of availability
read more

CB1 and CB2 receptors play differential roles in early zebrafish locomotor development

Scientists found that blocking CB1 receptors and CB2-receptors in young zebrafish resulted in morphological deficits, reductions in heart rate, and non-inflated swim bladders. These findings indicate that the endocannabinoid system is pivotal to the development of the locomotor system in zebrafish, and that disturbances to the endocannabinoid system in early life may have detrimental effects.

The translation of these effects to humans is obviously not direct, but it is important for science to learn about safety and expected effects, to examine how chemistry interacts in petri dishes, how basic organic/animal functions are impacted in a living thing, and when the time is appropriate, to then assess any effects in humans

View this review (yellow link) or download:

This paper is also stored here:   http://bit.ly/2YfykgI      inside the CED Foundation Archive

To explore related information, click the keywords below:

Benjamin Caplan, MDCB1 and CB2 receptors play differential roles in early zebrafish locomotor development
read more

Massachusetts enshrines education requirements into the cannabis standard of care

Kudos to the Massachusetts Cannabis Control Commission for implementing a regulatory standard to ensure a sustained opportunity for education and knowledge improvement into the state’s cannabis industry and community.

Massachusetts has consistently shown outstanding leadership in the healthcare arena, and it’s thrilling to see that cannabis is treated no differently.

Already leading the cutting edge of research, education, and cannabis formulation development, CED Foundation is ready & eager to support our industry colleagues with education and guidance, here in MA, and worldwide.

Benjamin Caplan, MDMassachusetts enshrines education requirements into the cannabis standard of care
read more

Nutritional Supplements Modulate Cannabinoid Content

Title: Impact of N, P, K and humic acids supplementation on the chemical profile of medical cannabis (Cannabis sativa L)

A recent study has come out revealing the effects of nutritional supplements (plant food) on cannabinoid content during the growth of the cannabis plant.

Researchers enhanced nutritional supplements such as humic acids and inorganic nitrogen and potassium and determined that the changes in supplement levels caused variations in the cannabinoid content of the plant organs. This research has demonstrated that maintaining specific nutritional supplements effects the chemical properties of cannabis plants and may play a role in standardizing the cannabinoid content in plants, no matter the region of growth. This knowledge may one day help cultivators with the process of standardizing cultivars, and perhaps help organize strain names and content across state lines.

This work spotlights the inconsistency between cannabis plants, even if they share the same name. The nutrients cannabis plants grow in have been proven to alter the cannabinoid content which changes (sometimes drastically) the effects felt by patients who consume that plant. Growers or enthusiasts who grow cannabis at home may be buying seeds from a known strain, but the same seeds produce a completely different strain, depending on the growing conditions. Standardizing growth conditions will hopefully help cultivators produce strains of the same name with consistent cannabinoid content, making buying safer and somewhat more uniformly regulatable. 

Tweet: A recent study has come out revealing the effects of #nutritional supplements on #cannabinoid content during #cannabis plant growth. Read this and other linked studies:

View this review (yellow link) or download:

This paper is also stored here:      http://bit.ly/2SigULd   inside the CED Foundation Archive

To explore related information, click the keywords below:

Benjamin Caplan, MDNutritional Supplements Modulate Cannabinoid Content
read more

Video: The Endocannabinoid System

A simplified overview of the human side of the human-cannabis interaction system!

Built from the growing mountain of literature inside the CED Foundation Medical Cannabis Archive

To explore related information, click the keywords below:

Benjamin Caplan, MDVideo: The Endocannabinoid System
read more